We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+9.41%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$130M
AUM Growth
+$11.7M
Cap. Flow
+$893K
Cap. Flow %
0.69%
Top 10 Hldgs %
23.8%
Holding
95
New
6
Increased
26
Reduced
41
Closed
1

Top Sells

Rank Stock Value
1
AA icon
Alcoa
AA
+$398K
2
EFOR
Everforth Inc
EFOR
+$246K
3
MMM icon
3M
MMM
+$157K
4
GE icon
GE Aerospace
GE
+$156K
5
CL icon
Colgate-Palmolive
CL
+$144K

Sector Composition

Rank Sector Weight
1 Industrials 14.15%
2 Technology 13.24%
3 Consumer Staples 11.19%
4 Healthcare 10.81%
5 Financials 9.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AA icon
26
Alcoa
AA
$11.7B
$2.14M 1.65%
83,885
-17,951
-18% -$398K
HYG icon
27
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$2.12M 1.63%
22,858
-219
-0.9% -$20.3K
ACN icon
28
Accenture
ACN
$101B
$2.12M 1.63%
25,731
+2,106
+9% +$159K
LH icon
29
Labcorp
LH
$25.8B
$2.1M 1.61%
26,732
+2,259
+9% +$193K
ADP icon
30
Automatic Data Processing
ADP
$106B
$2.06M 1.58%
29,030
-1,044
-3% -$70.2K
CHRW icon
31
C.H. Robinson
CHRW
$20B
$2.05M 1.58%
35,160
+2,090
+6% +$123K
CVS icon
32
CVS Health
CVS
$140B
$2.05M 1.57%
28,617
-667
-2% -$42.9K
XLU icon
33
State Street Utilities Select Sector SPDR ETF
XLU
$23.4B
$2M 1.54%
105,540
-296
-0.3% -$5.66K
CL icon
34
Colgate-Palmolive
CL
$74.2B
$1.99M 1.53%
30,530
-2,244
-7% -$144K
BNY
35
Bank of New York Mellon
BNY
$106B
$1.88M 1.45%
53,908
-1,493
-3% -$48.6K
EWC icon
36
iShares MSCI Canada ETF
EWC
$6.18B
$1.83M 1.41%
62,745
+3,145
+5% +$91K
CMCSK
37
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$1.81M 1.4%
36,393
+93
+0.3% +$4.64K
COP icon
38
ConocoPhillips
COP
$139B
$1.81M 1.39%
25,579
+159
+0.6% +$11.4K
VB icon
39
Vanguard Small-Cap ETF
VB
$80.2B
$1.81M 1.39%
16,438
-607
-4% -$64.6K
COV
40
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$1.8M 1.39%
26,483
-359
-1% -$23.4K
EFA icon
41
iShares MSCI EAFE ETF
EFA
$76.8B
$1.73M 1.33%
25,784
-1,238
-5% -$80.9K
IJR icon
42
iShares Core S&P Small-Cap ETF
IJR
$110B
$1.62M 1.25%
29,720
-300
-1% -$15.7K
OMC icon
43
Omnicom Group
OMC
$24.6B
$1.61M 1.23%
21,600
-635
-3% -$43.7K
T icon
44
AT&T
T
$169B
$1.58M 1.22%
59,720
+66
+0.1% +$1.74K
OIH icon
45
VanEck Oil Services ETF
OIH
$1.99B
$1.52M 1.17%
1,578
+41
+3% +$39.9K
ABBV icon
46
AbbVie
ABBV
$465B
$1.45M 1.11%
27,403
+535
+2% +$26.3K
CVX icon
47
Chevron
CVX
$374B
$1.37M 1.05%
10,949
-248
-2% -$30K
XLE icon
48
State Street Energy Select Sector SPDR ETF
XLE
$38.3B
$1.31M 1.01%
29,724
-30
-0.1% -$1.29K
ABT icon
49
Abbott
ABT
$187B
$1.14M 0.88%
29,854
+3,542
+13% +$131K
VTI icon
50
Vanguard Total Stock Market ETF
VTI
$656B
$1.12M 0.86%
11,680

Similar funds

Boston Research & Management's Q4 2013 Portfolio in Review

As of Q4 2013, Boston Research & Management held 95 positions worth $130M, up 9.9% from $118M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Boston Research & Management's Q4 2013 filing shows 6 new, 26 increased, 41 reduced and 1 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 1,790 shares worth $332K. The largest sale was Alcoa, an estimated $398K.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Staples.

  • Boston Research & Management's largest Q4 2013 buy was iShares Core S&P 500 ETF: 1,790 shares worth $332K.
  • Boston Research & Management added most to Cisco in Q4 2013, an estimated $339K increase.
  • Boston Research & Management's biggest Q4 2013 reduction was Alcoa, cutting an estimated $398K.
  • Boston Research & Management fully exited Everforth Inc in Q4 2013, selling an estimated $246K.
  • Boston Research & Management's ten largest holdings make up 24% of its $130M portfolio in Q4 2013.
  • Boston Research & Management opened 6 new positions and closed 1 in Q4 2013.
  • Boston Research & Management's portfolio value rose 9.9% quarter-over-quarter to $130M.

Based on Boston Research & Management's 13F filing for Q4 2013, filed 7 Feb 2014.